Literature DB >> 24615755

Natural pesticide dihydrorotenone arrests human plasma cancer cells at the G0/G1 phase of the cell cycle.

Xin Xu1, Jieyu Zhang, Kunkun Han, Zubin Zhang, Guodong Chen, Jinping Zhang, Xinliang Mao, Biyin Cao.   

Abstract

Dihydrorotenone (DHR) is a natural pesticide used for farming including organic produces. We recently found that DHR induces human plasma cell apoptosis by provoking endoplasmic reticulum stress. In the present study, we found that DHR arrested human plasma cancer cells at the G0/G1 phase of the cell cycle. Mechanistical studies demonstrated that cell cycle arrest was associated with downregulated cell cycle promotors including cyclin D2, cyclin D3, cyclin-dependent kinases (CDK4, CKD6), and phosphorylated-Rb. DHR inhibited cyclin D2 transactivation, thus inhibiting its mRNA expression. In addition, DHR upregulated the cell cycle repressors p21 and p53. DHR also increased the phosphorylation level of p53, suggesting the upregulated transactivation function of p53, which was confirmed by the induction of p21, a substrate of activated p53. Moreover, DHR downregulated AKT and ERK phosphorylation, an incentive of cell cycle progression. Therefore, these results collectively demonstrated that DHR disrupts the cell cycle progress, which suggests that DHR is toxic to human plasma cells. Caution is thus suggested when handling with this agent.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Cell Cycle; Cell Proliferation; Dihydrorotenone; Pesticide; Plasma Cell

Mesh:

Substances:

Year:  2014        PMID: 24615755     DOI: 10.1002/jbt.21558

Source DB:  PubMed          Journal:  J Biochem Mol Toxicol        ISSN: 1095-6670            Impact factor:   3.642


  6 in total

1.  Fangchinoline inhibits the proliferation of SPC-A-1 lung cancer cells by blocking cell cycle progression.

Authors:  Xue Luo; Jian-Ming Peng; Lan-DI Su; Dong-Yan Wang; You-Jiang Yu
Journal:  Exp Ther Med       Date:  2015-12-04       Impact factor: 2.447

2.  An inhibitor of cholesterol absorption displays anti-myeloma activity by targeting the JAK2-STAT3 signaling pathway.

Authors:  Xin Xu; Kunkun Han; Jingyu Zhu; Hongwu Mao; Xu Lin; Zubin Zhang; Biyin Cao; Yuanying Zeng; Xinliang Mao
Journal:  Oncotarget       Date:  2016-11-15

3.  Knockdown of RNF6 inhibits gastric cancer cell growth by suppressing STAT3 signaling.

Authors:  Ziming Huang; Yong Cai; Chenchen Yang; Zhen Chen; Hong Sun; Yingying Xu; Wei Chen; Dafu Xu; Wenze Tian; Haixiao Wang
Journal:  Onco Targets Ther       Date:  2018-10-05       Impact factor: 4.147

4.  The natural polyphenol curcumin induces apoptosis by suppressing STAT3 signaling in esophageal squamous cell carcinoma.

Authors:  Ying Liu; Xinhua Wang; Shuang Zeng; Xiane Zhang; Jimin Zhao; Xiaoyan Zhang; Xinhuan Chen; Wanjing Yang; Yili Yang; Ziming Dong; Jingyu Zhu; Xin Xu; Fang Tian
Journal:  J Exp Clin Cancer Res       Date:  2018-12-05

5.  New screening system using Twist1 promoter activity identifies dihydrorotenone as a potent drug targeting cancer-associated fibroblasts.

Authors:  Eunmyong Lee; So-Young Yeo; Keun-Woo Lee; Jin A Lee; Kyeong Kyu Kim; Seok-Hyung Kim
Journal:  Sci Rep       Date:  2020-04-27       Impact factor: 4.379

6.  Inhibition of Ubiquitin Specific Protease 1 Sensitizes Colorectal Cancer Cells to DNA-Damaging Chemotherapeutics.

Authors:  Xin Xu; Shaoyan Li; Ximao Cui; Kunkun Han; Jun Wang; Xiaodan Hou; Long Cui; Songbing He; Jiecheng Xiao; Yili Yang
Journal:  Front Oncol       Date:  2019-12-18       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.